Nomura Holdings
NKTR icon

Nomura Holdings’s Nektar Therapeutics NKTR Stock Holding History

Nomura Holdings’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,233
Closed -$453K – 2274
2021
Q4 		$453K Buy
+2,233
New +$484K ﹤0.01% 1546

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nomura Holdings's NKTR Position: Q2 2026 in Review

Nomura Holdings opened a new position in Nektar Therapeutics (NKTR) in Q2 2026: 38,657 shares worth $2.7M. The stake represents ﹤0.01% of the portfolio and ranks #1007 among its holdings. This is a return to the name: Nomura Holdings previously reported a position in NKTR as recently as Q1 2022.

Nomura Holdings first reported a position in NKTR in Q2 2013 and has held it in 9 quarters since. The position peaked at $3.37M in Q1 2018. 239 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

  • Nomura Holdings held 38,657 shares of Nektar Therapeutics worth $2.7M as of Q2 2026.
  • Nektar Therapeutics was a new Nomura Holdings position in Q2 2026.
  • Nektar Therapeutics made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #1007 holding.
  • Nomura Holdings first reported a position in Nektar Therapeutics in Q2 2013 and has held it in 9 quarters since.
  • Nomura Holdings's Nektar Therapeutics position peaked at $3.37M in Q1 2018.
  • 239 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.